TCL Archive ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies May 2, 2003
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001